728
Views
0
CrossRef citations to date
0
Altmetric
News, Policy, & Profiles

Human Vaccines & Immunotherapeutics: news

References

  • De Souza WM, Amorim MR, Sesti-Costa R, Coimbra LD, De Toledo-teixeira DA, Parise PL, Barbosa PP, Bispo-dos-santos K, Mofatto LS, Simeoni CL, et al. Levels of SARS-CoV-2 lineage P.1 neutralization by antibodies elicited after natural infection and vaccination. SSRN [Preprint]. 2021. doi:10.2139/ssrn.3793486.
  • Jones NK, Rivett L, Workman C, Ferris M, Shaw A, Lehner PJ, Howes R, Wright G, Matheson NJ, Weekes MP,, . Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. Authorea [Preprint]. 2021. doi:10.22541/au.161420511.12987747/v1.
  • Baird JK, Jensen SM, Urba WJ, Fox BA, Baird JR. SARS-CoV-2 antibodies detected in human breast milk post-vaccination. medRxiv [Preprint]. 2021. doi:10.1101/2021.02.23.21252328.
  • Sims EK, Bundy BN, Stier K, Serti E, Lim N, Long SA, Geyer SM, Moran A, Greenbaum CJ, Evans-Molina C, et al., Type 1 Diabetes TrialNet Study Group. Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals. Sci Transl Med. 2021;13(583):eabc8980. doi:10.1126/scitranslmed.abc8980.
  • Foster MC, Savoldo B, Lau W, Rubinos CA, Grover N, Armistead PM, Coghill JM, Hagan RS, Morrison JK, Cheng C, et al. Utility of safety switch to abrogate CD19.CAR T cell-associated neurotoxicity. Blood. 2021. doi:10.1182/blood.2021010784.
  • Paul S, Pearlman AH, Douglass J, Mog BJ, Hsiue EH, Hwang MS, DiNapoli SR, Konig MF, Brown PA, Wright KM, et al. TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Sci Transl Med. 2021;13(584):eabd3595. doi:10.1126/scitranslmed.abd3595.
  • Hsiue EH, Wright KM, Douglass J, Hwang MS, Mog BJ, Pearlman AH, Paul S, DiNapoli SR, Konig MF, Wang Q, et al. Targeting a neoantigen derived from a common TP53 mutation. Science. 2021;371(6533):eabc8697. doi:10.1126/science.abc8697.
  • Douglass J, Hsiue EH, Mog BJ, Hwang MS, DiNapoli SR, Pearlman AH, Miller MS, Wright KM, Azurmendi PA, Wang Q, et al. Bispecific antibodies targeting mutant RAS neoantigens. Sci Immunol. 2021;6(57):eabd5515. doi:10.1126/sciimmunol.abd5515.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.